Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SNGX
#4823
Soligenix, Inc. Common Stock
1.150
0
USD
0.00%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
0.00%
Monthly Change
-8.00%
6 month change
+1.77%
Year Change
+1.77%
Previous Close
1.150
0
Open
1.150
0
Bid
Ask
Low
1.150
0
High
1.150
0
Volume
5
Markets
US Stock Market
Healthcare
SNGX
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
166.92 K
179.15 K
182.78 K
657.78 K
3.16 M
10.31 M
—
Valuation ratios
Enterprise value
42.97 M
2.32 M
32.46 M
10.07 M
8.62 M
13.81 M
38.14 M
Price to earnings ratio
—
-2.13
-1.51
-1.08
-0.54
-0.63
-2.28
Price to sales ratio
—
32.15
22.01
7.86
37.49
-588.54
-74.35
Price to cash flow ratio
—
-2.26
-1.65
-0.77
-0.53
-0.68
-1.78
Price to book ratio
—
2.47
-8.45
2.61
1.09
1.31
1.93
Enterprise value to EBITDA ratio
-2.46
-1.1
-2.29
-1.31
—
—
—
Profitability ratios
Return on assets %
-0.89
-0.47
-0.97
-0.63
-0.92
-1.2
-1.39
Return on equity %
-4.73
-1.17
5.58
-2.43
-2.01
-2.09
-3.2
Return on invested capital %
-5 823.7
-4 020.74
—
—
—
—
—
Gross margin %
22.82
11.6
41.95
11.59
0
127.29
1 121.87
Operating margin %
-787.75
-1 594.25
-1 500.55
-917.12
-7 907.7
100.27 K
2.64 M
EBITDA margin %
-785.1
-1 590.1
-1 496.17
-915.63
—
—
—
Net margin %
-749.69
-1 522.68
-1 454.12
-731.6
-6 925.11
93.79 K
2.11 M
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
3.2
4.22
0.84
1.55
1.82
2.39
8.95
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.17
0.04
0.05
0.07
0.01
-0
-0
Solvency ratios
Debt to assets ratio
0.52
0
0.78
0.11
0.01
—
—
Debt to equity ratio
2.79
0
-4.53
0.45
0.03
—
—
Long term debt to total assets ratio
0.66
0.45
0.77
0.1
0
—
—
Long term debt to total equity ratio
3.5
1.12
-4.43
0.4
0
—
—
Per share metrics
Operating cash flow per share
—
-70.14
-70.48
-17.74
-5.06
-1.98
-2.65
EBIT per share
—
-78.51
-79.34
-15.88
-5.69
-2.29
-3.2
EBITDA per share
—
-78.3
-79.11
-15.85
—
—
—
Total debt per share
—
0
62.33
2.32
0.07
—
—
Cash per share
—
155.59
—
—
—
—
—
Net current asset value per share
—
158.73
77.19
19.61
5.32
1.71
8.35
Tangible book value per share
—
64.06
-13.77
5.2
2.48
1.02
4.52
Working capital per share
—
121.15
-14.84
6.92
2.4
0.99
4.42
Book value per share
—
64.06
-13.77
5.2
2.48
1.02
4.52
News
Soligenix receives UK regulatory designation for Behçet’s drug
Soligenix receives positive EMA opinion for orphan drug status
Soligenix stock rises after positive Behçet’s Disease treatment data
Soligenix reports positive results from SGX945 trial for Behçet’s disease
Soligenix Psoriasis Trial Extension Shows Better Outcomes With New Gel - Soligenix (NASDAQ:SNGX)
Soligenix reports positive results from psoriasis gel treatment trial
First patient dosed in Synairgen’s global phase 2 INVENT study
Soligenix hits enrollment target for CTCL treatment interim analysis
Soligenix updates medical advisory board for lymphoma treatment
Soligenix stock soars after DMC confirms safety in Phase 3 CTCL study
Soligenix reports safety milestone in phase 3 CTCL treatment trial
Soligenix expands European medical advisory board for lymphoma treatment